Capital One Discloses AML Probe Behind Trump Organization Account Closures: Investor Implications for COF
Capital One formally disclosed its anti-money laundering rationale for closing 300+ Trump Organization accounts in a landmark August 1 court filing. The disclosure creates dual legal-regulatory risk for COF as it integrates Discover Financial — and may set a precedent for how U.S. banks must publicly defend AML compliance decisions.
- 02
AstraZeneca Explores $400B Bristol-Myers Squibb Mega-Merger: Antitrust, Oncology, and What It Means for Korean CDMOs
Bloomberg and the Financial Times report that AstraZeneca has held preliminary discussions about acquiring Bristol-Myers Squibb in a deal that could create a $400 billion pharmaceutical giant. The combination would face three-jurisdiction antitrust review, while Korean CDMO Samsung Biologics stands as a potential beneficiary of the enlarged pipeline.
- 03
Medtronic FY2026: Sales Up 8.4% to $36.4B, Every Segment Loses Margin
Balance sheet, income statement and segment figures are taken from Medtronic plc's Form 10-K for the fiscal year ended April 24, 2026, filed with the SEC on Jun
- 04
Visa Eliminates 2,600 Jobs as AI Reshapes Payments: What Investors Need to Know
Visa announced 2,600 layoffs (7% of workforce) on July 28, 2026, the same day it reported Q3 FY2026 net revenue of USD 11.6B (+14% YoY). CEO McInerney cited AI-driven efficiency; USD 563M severance charge booked. Value-Added Services surged 34% YoY to USD 3.8B. Wall Street consensus: Strong Buy, avg target USD 401.
- 05
S&P Global (SPGI) Q2 2026: Ratings, Indices Power 23% EPS Beat as USD 7B Buyback Signals Confidence
S&P Global Q2 2026 earnings: Adj. EPS USD 4.83 (+23% YoY) beat USD 4.49 consensus by 7.6%. Ratings revenue +17%, Indices 13th consecutive record quarter (+20%). USD 7B buyback raised. SPGI stock fell ~5% as Mobility Global (MBGL) spin-off reshapes valuation.
- 06
August 7 U.S. Jobs Report: Why the Fed's 9-3 Split Makes Friday Critical for KOSPI Investors
Aug 7 BLS report arrives after the Fed's 9-3 split and June's 57K print. What Korean equity and currency investors need to watch Friday — KOSPI, KRW, Naver Q2.
- 07
Aflac (AFL) Q1 2026: Net Earnings 35x to $1.02B, Core Flat
Aflac's net earnings went from $29 million to $1,019 million and diluted EPS from $0.05 to $1.98 — but the underlying insurance business earned almost exactly what it earned a year ago. Pretax adjuste
- 08
AbbVie Q2 2026: SKYRIZI Matches Humira's Historic Peak as Apogee Deal Trims EPS Outlook
AbbVie beat Q2 2026 revenue estimates with USD 16.99B (+10.2%), driven by SKYRIZI matching Humira's all-time quarterly peak at USD 5.5B. Shares fell ~2% after the company trimmed full-year EPS guidance by USD 0.14/share to absorb the pending USD 10.9B Apogee Therapeutics acquisition, expected to close Q3 2026.
- 09
Korea Value-Up Program: 2026 Status, Index Performance, and What Investors Need to Know
741 Korean companies (85.5% mkt cap) enrolled. Value-Up Index ATH 3,977. Mar 2026 Act mandates treasury cancellations. MSCI upgrade path and investor guide.
LineVest Daily
Get this wrap in your inbox every morning.
One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.
Subscribe free